Records containing: Pulmonary Arterial Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-01-29Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-01-28Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism
-
CLINICAL_TRIALS study record update · 2019-12-26An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients.
-
CLINICAL_TRIALS study record update · 2019-12-09Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-11-15The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study (The CAPS-PAH Study)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-10-08An Open-Label, Dose Titration Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046, A Sustained-Release Analogue of Vasoactive Intestinal Peptide, In Adult Subjects With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-10-08Prospective, Multicenter, Open-label Study Evaluating the Effects of First-line Oral Combination Therapy of Macitentan and Tadalafil in Patients With Newly Diagnosed Pulmonary Arterial Hypertension (OPTIMA).
-
CLINICAL_TRIALS study record update · 2019-10-07A Phase 2, Open-label, Clinical Trial of Fluoxetine, a Selective Serotonin Reuptake Inhibitor, in the Treatment of Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-09-16An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
-
CLINICAL_TRIALS study record update · 2019-08-26Imaging of Ventricular Reversed Remodeling After Double Lung Transplantation in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-08-20The Effect of Adding Exercise Training to Optimal Therapy in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-08-12Morbidity and Outcomes of Pregnant Women With Pulmonary Arterial Hypertension During Different Pregnancies
-
CLINICAL_TRIALS study record update · 2019-08-07A Randomized, Parallel-group, Placebo-controlled Subject and Investigator Blinded Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of QCC374 in the Treatment of Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-07-22A Single Rising Dose Clinical Trial to Study the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8892
-
CLINICAL_TRIALS study record update · 2019-07-16Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH
-
CLINICAL_TRIALS study record update · 2019-05-22DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL
-
CLINICAL_TRIALS study record update · 2019-05-22Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-05-21A Multicenter, Open-label, Single-sequence Cross-over Study to Assess Safety, Tolerability, and Pharmacokinetics of Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension Switching From an Oral Stable Dose of Selexipag
-
CLINICAL_TRIALS study record update · 2019-05-03A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JTT-251 Administered for 24 Weeks to Participants With Pulmonary Arterial Hypertension (RELIEF-PAH)
-
CLINICAL_TRIALS study record update · 2019-05-01A Nation-wide Multicenter Registry and Biobank Program for Deep Phenotyping of Idiopathic and Hereditary Pulmonary Arterial Hypertension in Korea: the PAH Platform for Deep Phenotyping in Korean Subjects (PHOENIKS) Cohort
-
CLINICAL_TRIALS study record update · 2019-04-16Long Term, Single-arm, Open-label Extension Study of Protocol AC-055-305 to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
-
CLINICAL_TRIALS study record update · 2019-04-10A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-04-08A Safety and Clinical Efficacy Study Measuring Echocardiographic Composite Comparing Ambrisentan (Letairis®) After a Switch From Bosentan (Tracleer®) or Macintentan (Opsumit®) in Treatment of Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2019-04-05Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-02-18A Prospective Study Comparing the REpeatability and Sensitivity to Change of Non-invasive Endpoints in Pulmonary arterIal hypeRtEnsion